2024 - The Data Leader’s Role in Measuring and Communicating the Value of Real-world Data
Date2024-10-30
Deadline2024-10-30
VenueONLINE-VIRTUAL, USA - United States
KeywordsLife Sciences; Pharmaceutical; Commercialization & HEOR
- Big Data, Data Science & Machine Learning
- 10th International Conference on Big Data Analytics, Data Mining and Computational Intelligence 2025
- 6th International Conference on Big Data (CBDA 2025)
- 6th International Conference on Big Data, Machine Learning and IoT (BMLI 2025)
- 6th International Conference on Cloud, Big Data and Web Services (CBW 2025)
Topics/Call fo Papers
Real-world data have become an essential resource for life sciences companies working across the product life cycle. But, mounting financial pressures in the industry have led to heightened scrutiny around these investments. The difficulty that many organizations face in effectively communicating the impact of these data and their outputs only compounds the problem.
It is crucial for leaders to articulate the value of these data across the enterprise, demonstrating their impact on the business and advocating for continued investment. With industry dynamics such as evolving regulatory requirements, highly competitive therapeutic markets and the rise of precision medicine, data and evidence are more crucial than ever before to produce high-quality research and meet organizational goals.
In this webinar, speakers specializing in real-world evidence will discuss the current challenges and opportunities in determining the value of real-world data. They will explore strategies for framing the value narrative within an organization and provide vital insights for success.
Register for this webinar today to gain insights into how to effectively communicate the value of real-world data investments across biopharmaceutical organizations.
Keywords: Real-World Data, Real-World Evidence, Clinical Data, Regulatory, HEOR, RWE, Health Economics Outcomes Research, Data Science, Commercialization/HEOR/Market Access, RWD
It is crucial for leaders to articulate the value of these data across the enterprise, demonstrating their impact on the business and advocating for continued investment. With industry dynamics such as evolving regulatory requirements, highly competitive therapeutic markets and the rise of precision medicine, data and evidence are more crucial than ever before to produce high-quality research and meet organizational goals.
In this webinar, speakers specializing in real-world evidence will discuss the current challenges and opportunities in determining the value of real-world data. They will explore strategies for framing the value narrative within an organization and provide vital insights for success.
Register for this webinar today to gain insights into how to effectively communicate the value of real-world data investments across biopharmaceutical organizations.
Keywords: Real-World Data, Real-World Evidence, Clinical Data, Regulatory, HEOR, RWE, Health Economics Outcomes Research, Data Science, Commercialization/HEOR/Market Access, RWD
Other CFPs
- Unlocking CRISPR: Advances in Base Editing, Prime Editing and Future Applications
- Accelerating Psychiatry Clinical Trials Through a Patient-Centric Approach: Real Patients, Real Outcomes
- Empowering Scientific Breakthroughs: How Scientists Can Use AI and ML for Drug Discovery
- Unlocking New Paths for Cardiac Care: A Practical Guide to Implementing Echocardiogram Services
- Expanding CAR T Beyond Oncology: Medical, Operational & Practical Considerations
Last modified: 2024-09-17 05:19:56